Universe Pharmaceuticals Stock Price Prediction

UPC Stock  USD 1.93  0.14  7.82%   
The RSI of Universe Pharmaceuticals' share price is below 30 at the present time. This usually implies that the stock is becoming oversold or undervalued. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling Universe Pharmaceuticals, making its price go up or down.

Oversold Vs Overbought

22

 
Oversold
 
Overbought
The successful prediction of Universe Pharmaceuticals' future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Universe Pharmaceuticals, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Universe Pharmaceuticals' stock price prediction:
Quarterly Earnings Growth
(0.82)
Quarterly Revenue Growth
(0.30)
Using Universe Pharmaceuticals hype-based prediction, you can estimate the value of Universe Pharmaceuticals from the perspective of Universe Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Universe Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Universe because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Universe Pharmaceuticals after-hype prediction price

    
  USD 1.79  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Universe Pharmaceuticals Basic Forecasting Models to cross-verify your projections.
For information on how to trade Universe Stock refer to our How to Trade Universe Stock guide.
Intrinsic
Valuation
LowRealHigh
0.091.7214.55
Details
Naive
Forecast
LowNextHigh
0.178.6221.45
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
1.263.635.99
Details

Universe Pharmaceuticals After-Hype Price Prediction Density Analysis

As far as predicting the price of Universe Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Universe Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Universe Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Universe Pharmaceuticals Estimiated After-Hype Price Volatility

In the context of predicting Universe Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Universe Pharmaceuticals' historical news coverage. Universe Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.09 and 14.62, respectively. We have considered Universe Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
1.93
1.79
After-hype Price
14.62
Upside
Universe Pharmaceuticals is abnormally volatile at this time. Analysis and calculation of next after-hype price of Universe Pharmaceuticals is based on 3 months time horizon.

Universe Pharmaceuticals Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Universe Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Universe Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Universe Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  3.65 
12.90
  0.95 
  0.22 
7 Events / Month
6 Events / Month
In about 7 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
1.93
1.79
0.00 
4,962  
Notes

Universe Pharmaceuticals Hype Timeline

On the 22nd of November Universe Pharmaceuticals is traded for 1.93. The entity has historical hype elasticity of 0.95, and average elasticity to hype of competition of 0.22. Universe is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is projected to be very small, whereas the daily expected return is at this time at -3.65%. %. The volatility of related hype on Universe Pharmaceuticals is about 21191.55%, with the expected price after the next announcement by competition of 2.15. The company has Price to Book (P/B) ratio of 0.11. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Universe Pharmaceuticals recorded a loss per share of 76.35. The entity had not issued any dividends in recent years. The firm had 1:15 split on the 18th of November 2024. Considering the 90-day investment horizon the next projected press release will be in about 7 days.
Check out Universe Pharmaceuticals Basic Forecasting Models to cross-verify your projections.
For information on how to trade Universe Stock refer to our How to Trade Universe Stock guide.

Universe Pharmaceuticals Related Hype Analysis

Having access to credible news sources related to Universe Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Universe Pharmaceuticals' future price movements. Getting to know how Universe Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Universe Pharmaceuticals may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
RGCRegencell Bioscience Holdings(0.21)12 per month 0.00 (0.02) 22.58 (10.93) 43.32 
VRTHFVeritas Pharma 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
EGRXEagle Pharmaceuticals(0.59)26 per month 0.00 (0.19) 9.24 (8.24) 53.71 
SGBISangui Biotech International 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
QLIQilian International Holding 1.35 3 per month 6.62  0.16  19.23 (12.37) 61.58 
IMCCIm Cannabis Corp(0.01)3 per month 4.31 (0) 6.73 (7.77) 29.32 
RAPHRaphael Pharmaceutical 0.00 0 per month 0.00 (0.13) 0.00  0.00  84.24 
GSACGelStat Corp 0.00 0 per month 11.04  0.07  33.33 (25.00) 58.33 
SSICSilver Spike Investment(0.20)6 per month 1.04  0.04  2.89 (1.82) 7.09 
PROCProcaps Group SA(0.08)2 per month 0.00 (0.02) 8.74 (12.37) 63.61 
SHPHFSihuan Pharmaceutical Holdings 0.00 0 per month 0.00  0.10  0.00  0.00  0.00 
PAHCPhibro Animal Health 0.49 10 per month 1.63  0.12  5.36 (2.45) 15.47 
PROCWProcaps Group SA(0.01)2 per month 0.00 (0.08) 26.79 (32.09) 78.66 
TKNOAlpha Teknova 0.17 4 per month 5.17  0.09  12.84 (8.91) 32.06 
SHMNSohm Inc 0.00 0 per month 0.00 (0.06) 11.11 (11.11) 38.18 

Universe Pharmaceuticals Additional Predictive Modules

Most predictive techniques to examine Universe price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Universe using various technical indicators. When you analyze Universe charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Universe Pharmaceuticals Predictive Indicators

The successful prediction of Universe Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Universe Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Universe Pharmaceuticals based on analysis of Universe Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Universe Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Universe Pharmaceuticals's related companies.
 2023 2024 (projected)
Dividend Yield0.0091690.009627
Price To Sales Ratio1.841.75

Story Coverage note for Universe Pharmaceuticals

The number of cover stories for Universe Pharmaceuticals depends on current market conditions and Universe Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Universe Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Universe Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Universe Pharmaceuticals Short Properties

Universe Pharmaceuticals' future price predictability will typically decrease when Universe Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Universe Pharmaceuticals often depends not only on the future outlook of the potential Universe Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Universe Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding3.6 M
Cash And Short Term Investments18.5 M

Complementary Tools for Universe Stock analysis

When running Universe Pharmaceuticals' price analysis, check to measure Universe Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Universe Pharmaceuticals is operating at the current time. Most of Universe Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Universe Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Universe Pharmaceuticals' price. Additionally, you may evaluate how the addition of Universe Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Equity Valuation
Check real value of public entities based on technical and fundamental data